ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1658

Regulatory Role of  the IL-9/IL-9R System  on Pannus Formation in Psoriatic Arthritis

Siba P. Raychaudhuri1,2 and Smriti K. Raychaudhuri3, 1Davis, CA, 2Rheumatology, Univ of California, Davis & VAMC Sacramento, Davis, CA, 3Rheumatology/Immunology, VA Sacramento Medical Center, Davis, CA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: cytokines, pathogenesis, psoriatic arthritis and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology - Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

   

Background/Purpose:  Earlier we have reported that synovial tissues of psoriatic arthritis (PsA) and rheumatoid arthritis (RA) are enriched with the Th9 cells along with its key cytokine IL-9 (1). Here we are reporting new functions of IL-9; its regulatory role on (i) FLS (fibroblast like synoviocyte) biology and (ii) pannus formation in PsA and RA.  

Methods : FLS were isolated from synovial tissue biopsies of PsA, RA and OA (n=5, for each) and cultured (1). IL-9R expression was determined by immunobloting and RT-PCR studies.  MTT assay and apoptosis assay (Annexin-V) were performed to determine the pro-growth/survival effect of rIL-9 on FLS. In the cultured FLS IL-6, IL-8, MMP-3 were measured by ELISA.

Results: RT-PCR and immunoblot studies demonstrated presence of IL9-R in FLS of PsA, RA and OA (Fig 1).  rIL-9 induced proliferation of FLS and inhibited TNF-a induced apoptosis (Fig 2). rIL-9 induced IL-6 and MMP-3 expression in FLS (Fig 3).   

Conclusion: Here we observed that FLS survival/prolifeartion, inflammatory cytokine expression and upregulation of MMP 3 the major components of the inflammatory proliferative cascades for pannus formation are regulated by IL-9. This is the first report to identify the presence of IL-9R on FLS and the functional significance of the IL-9/IL-9R system on FLS biology in PsA and RA. Figure 1. IL-9R is expressed in FLS –  IL-9R gene was expressed in FLS of PsA and RA patients. Compared to the unactivated T lymphocytes the relative gene expression of IL-9R in FLS of PsA and RA patients was 3.5±0.67, 2.4±0.5, respectively (p<.01, Fig 1).  IL-9R expression was confirmed by immunoblotting.  The relative intensity (R.I) of IL-9R in FLS of PsA, RA and OA patients was 0.3 ± 0.02, 0.37 ± 0.05, 0.28 ± 0.08 respectively.

  Figure 2. Human rIL-9 promoted survival of FLS– To test the functional significance of the IL9R we investigated whether rIL-9 can promote FLS survival. FLS of PsA, RA and OA were treated with rIL-9 (25 ng/ml) for 48hrs then TNFα (20 ng/ml) for 24 hours to induce apoptosis (1).  In the FLS of PsA, TNFα + rIL-9 induced 11.41±3.61% apoptosis compared to 35±5.53% induced apoptosis seen in TNFα alone (p<.01).  Similar results were seen in RA and OA FLS.

Figure 3. Compared to the untreated FLS, rIL-9 (100 ng/ml) induced upregulation of IL-6 and MMP- 3 (p<.01).  

Reference: 1. Raychaudhuri SK, et al. Cytokine 2016; 79:45-51.


Disclosure: S. P. Raychaudhuri, None; S. K. Raychaudhuri, None.

To cite this abstract in AMA style:

Raychaudhuri SP, Raychaudhuri SK. Regulatory Role of  the IL-9/IL-9R System  on Pannus Formation in Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/regulatory-role-of-the-il-9il-9r-system-on-pannus-formation-in-psoriatic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/regulatory-role-of-the-il-9il-9r-system-on-pannus-formation-in-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology